David Kuczek, General Partner at HV Capital, highlights Bioniq's growth in providing personalized health solutions for professional athletes worldwide.
Funds from the Series B round will be used for global market expansion, product development, and integrating a global laboratory network to disrupt the dietary supplements market.
CEO of Unbound, Shravin Mittal, praises Bioniq's innovative approach to nutrition, emphasizing the importance of personalized supplements tailored to individual needs.
Bioniq, launched in 2019, offers AI-driven supplements personalized based on blood test data, serving over 100,000 users with formulas created from a vast biochemical database.
Collection
[
|
...
]